![](/images/graphics-bg.png)
Durable Control of Mycosis Fungoides after Sepsis: “Coley’s Toxin?” Case Report and Review of the Literature
Joint Authors
Heyman, Benjamin
Kelsey, Chris R.
Beaven, Anne
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-08-04
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Mycosis fungoides, along with Sezary syndrome, is the most common subtype of cutaneous T-cell lymphoma.
In this report, we present a patient with advanced-stage mycosis fungoides, who after successful treatment of methicillin-resistant Staphylococcus aureus bacteremia had prolonged disease control off systemic therapy.
While this may have been due to single-agent gemcitabine, which can result in long remission, we hypothesize that our patient’s durable response was in part due to the immune response elicited after treatment of her severe infection.
American Psychological Association (APA)
Heyman, Benjamin& Kelsey, Chris R.& Beaven, Anne. 2019. Durable Control of Mycosis Fungoides after Sepsis: “Coley’s Toxin?” Case Report and Review of the Literature. Case Reports in Hematology،Vol. 2019, no. 2019, pp.1-4.
https://search.emarefa.net/detail/BIM-1136405
Modern Language Association (MLA)
Heyman, Benjamin…[et al.]. Durable Control of Mycosis Fungoides after Sepsis: “Coley’s Toxin?” Case Report and Review of the Literature. Case Reports in Hematology No. 2019 (2019), pp.1-4.
https://search.emarefa.net/detail/BIM-1136405
American Medical Association (AMA)
Heyman, Benjamin& Kelsey, Chris R.& Beaven, Anne. Durable Control of Mycosis Fungoides after Sepsis: “Coley’s Toxin?” Case Report and Review of the Literature. Case Reports in Hematology. 2019. Vol. 2019, no. 2019, pp.1-4.
https://search.emarefa.net/detail/BIM-1136405
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1136405